lutein 发表于 2025-3-21 17:45:56
书目名称High — Level Synthesis影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0426552<br><br> <br><br>书目名称High — Level Synthesis读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0426552<br><br> <br><br>血友病 发表于 2025-3-21 23:17:30
http://reply.papertrans.cn/43/4266/426552/426552_2.pngsemiskilled 发表于 2025-3-22 00:55:07
http://reply.papertrans.cn/43/4266/426552/426552_3.png法律 发表于 2025-3-22 05:51:38
http://reply.papertrans.cn/43/4266/426552/426552_4.pngEmg827 发表于 2025-3-22 08:52:28
Daniel D. Gajski,Nikil D. Dutt,Allen C-H Wu,Steve Y-L Linumed that the student has noprior knowledge of statistics. It is aimed primarily at business and economicsundergraduates, providing them with the basic statistical skills necessary forfurther study of their subject. However, students of other disciplines willalso find it relevant..978-3-319-79962-9978-3-319-26497-4orient 发表于 2025-3-22 16:31:16
Daniel D. Gajski,Nikil D. Dutt,Allen C-H Wu,Steve Y-L Linal data is presented consistently throughout the text. Academic researchers, practitioners and other users who work with statistical data will benefit from reading .Applied Statistics for Social and Management Sciences.. .978-981-10-9152-0978-981-10-0401-8Cursory 发表于 2025-3-22 20:28:55
http://reply.papertrans.cn/43/4266/426552/426552_7.pngSubstance 发表于 2025-3-23 01:13:41
http://reply.papertrans.cn/43/4266/426552/426552_8.pngaudiologist 发表于 2025-3-23 04:40:27
d, one is faced with the second problem of what appropriate margin to use when the control rate from the NI trial differs from the estimated control response rate. This question was raised by the FDA Anti-infective Division at the November 2011 Anti-infective Advisory Committee meeting. A hybrid desIndebted 发表于 2025-3-23 09:27:30
http://reply.papertrans.cn/43/4266/426552/426552_10.png